KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183 | -37.5% | 18,961 | -41.7% | 0.00% | – |
| Q2 2023 | $293 | +0.7% | 32,516 | -12.0% | 0.00% | – |
| Q1 2023 | $291 | +16.9% | 36,971 | +0.2% | 0.00% | – |
| Q4 2022 | $249 | -99.9% | 36,879 | +36.9% | 0.00% | – |
| Q3 2022 | $391,000 | +88.9% | 26,946 | +28.3% | 0.00% | – |
| Q2 2022 | $207,000 | -23.3% | 20,999 | +14.6% | 0.00% | – |
| Q1 2022 | $270,000 | +39.2% | 18,327 | +25.0% | 0.00% | – |
| Q4 2021 | $194,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |